| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/14/2023 | PDS Biotechnology Corp | EDGE | Grant | Employee Stock Option (Right to Buy) | 9k | $5.13 | $46.2k | | 07/14/2023 |
| 05/26/2023 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 30k | $1.32 | $39.6k | | 05/26/2023 |
| 05/26/2023 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 25k | $0.00 | $0 | | 05/26/2023 |
| 06/28/2022 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right to Buy) | 9k | $3.90 | $35.1k | | 06/28/2022 |
| 05/20/2022 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Common Stock | 18.8k | $0.00 | $0 | | 05/20/2022 |
| 05/20/2022 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 22.5k | $2.01 | $45.2k | | 05/20/2022 |
| 01/03/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 3.9k | $0.00 | $0 | | 01/03/2022 |
| 01/03/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 27.9k | $0.00 | $0 | | 01/03/2022 |
| 01/03/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Unit | 6.6k | $0.00 | $0 | | 01/03/2022 |
| 01/03/2022 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 7.1k | $0.00 | $0 | | 01/03/2022 |
| 12/16/2021 | RIGEL PHARMACEUTICALS INC | RIGL | Grant | Stock Option (Right to Buy) | 120k | $2.44 | $292.8k | | 12/16/2021 |
| 06/17/2021 | PDS Biotechnology Corp | EDGE | Grant | Stock Option (Right to Buy) | 9k | $9.95 | $89.6k | | 06/15/2021 |
| 06/15/2021 | PDS Biotechnology Corp | EDGE | Purchase | Common Stock | 11.8k | $8.50 | $100k | | 06/15/2021 |
| 06/03/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 9.5k | $21.96 | $208.4k | | 06/03/2021 |
| 06/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 2.4k | $22.31 | $53.3k | | 06/01/2021 |
| 06/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 12.7k | $21.51 | $273.8k | | 06/01/2021 |
| 06/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 2.5k | $22.32 | $56.2k | | 06/01/2021 |
| 06/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 12.5k | $21.50 | $268.4k | | 06/01/2021 |
| 06/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 5.3k | $23.57 | $123.9k | | 06/01/2021 |
| 06/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 9.7k | $22.72 | $221.4k | | 06/01/2021 |
| 06/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted Stock Units | 33.2k | $0.00 | $0 | | 06/01/2021 |
| 05/07/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 3.3k | $23.23 | $77k | | 05/06/2021 |
| 05/07/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 2.1k | $23.99 | $50.4k | | 05/06/2021 |
| 05/07/2021 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Employee Stock Option (Right to Buy) | 5.4k | $10.66 | $57.7k | | 05/06/2021 |
| 05/06/2021 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Employee Stock Option (Right to Buy) | 15k | $10.66 | $159.9k | | 05/06/2021 |
| 05/06/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 11.9k | $23.32 | $277.4k | | 05/06/2021 |
| 05/06/2021 | Aclaris Therapeutics, Inc. | ACRS | Sale | Common Stock | 3.1k | $23.86 | $74k | | 05/06/2021 |
| 03/11/2021 | Aclaris Therapeutics, Inc. | ACRS | Gift | Common Stock | 7.5k | $0.00 | $0 | | 03/11/2021 |
| 03/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted stock units | 6.6k | $0.00 | $0 | | 03/01/2021 |
| 03/02/2021 | Aclaris Therapeutics, Inc. | ACRS | Payment of Exercise | Common Stock | 1.9k | $23.25 | $44.3k | | 03/01/2021 |
| 03/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Grant | Employee Stock Option (Right to Buy) | 99.5k | $24.06 | $2.4M | | 03/01/2021 |
| 03/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Grant | Restricted stock units | 28.4k | $0.00 | $0 | | 03/01/2021 |
| 03/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Exercise | Restricted stock units | 17.2k | $0.00 | $0 | | 03/01/2021 |
| 03/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Payment of Exercise | Common Stock | 4.9k | $24.06 | $118.7k | | 03/01/2021 |
| 02/01/2021 | Aclaris Therapeutics, Inc. | ACRS | Payment of Exercise | Common Stock | 1.3k | $21.35 | $28.1k | | 02/01/2021 |
|